Dashboard
Manage Tickers

BCLIBRAINSTORM CELL THERAPEUTIC...

Nasdaq brainstorm-cell.com


$ 0.50 $ -0.05 (-8.74 %)    

Tuesday, 14-May-2024 15:44:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 0.5001
$ 0.53
$ 0.00 x 0
$ 0.00 x 0
$ 0.50 - $ 0.54
$ 0.13 - $ 3.34
489,503
na
32.38M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 04-26-2021 03-31-2021 10-Q
14 02-04-2021 12-31-2020 10-K
15 10-15-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-18-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 10-29-2018 09-30-2018 10-Q
24 07-23-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 10-17-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-29-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-09-2016 12-31-2015 10-K
35 11-16-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-26-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

brainstorm-cell-q1-2024-adj-eps-005-beats-007-estimate
Brainstorm Cell Q1 2024 Adj EPS $(0.05) Be...
05/14/2024 20:53:10

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.0...

brainstorm-cell-therapeutics-received-letter-from-nasdaq-indicating-co-had-not-regained-compliance-with-minimum-bid-price-requirement-by-april-29
Brainstorm Cell Therapeutics Received Lett...
05/03/2024 20:14:57

- SEC Filing

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

reported-earlier-brainstorm-cell-therapeutics-announces-management-changes-as-it-plans-registrational-phase-3b-trial-of-nurown
Reported Earlier, BrainStorm Cell Therapeu...
04/17/2024 06:54:01

Bob Dagher, MD, Promoted to Chief Medical Officer Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of D...

brainstorm-cell-therapeutics-regains-compliance-with-nasdaq-minimum-market-value-rule
BrainStorm Cell Therapeutics Regains Compl...
04/11/2024 10:02:49

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI, ", , the Company", , )))), a leading developer of cellular therapies fo...

brainstorm-cell-therapeutics-announced-peer-reviewed-publication-of-phase-3-biomarker-data-in-muscle-and-nerve-suggesting-that-debamestrocel-or-nurown-may-impact-key-biomarkers-in-amyotrophic-lateral-sclerosis-that-are-predictive-of-disease-progression
Brainstorm Cell Therapeutics Announced Pee...
04/10/2024 10:02:28

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 12:09:53

why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket
Why Biophytis Shares Are Trading Higher By...
04/09/2024 10:05:24

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

brainstorm-cell-therapeutics-received-written-agreement-from-fda-under-special-protocol-assessment-on-design-for-phase-3b-trial-of-nurown-in-amyotrophic-lateral-sclerosis-expected-to-start-in-2024
Brainstorm Cell Therapeutics Received Writ...
04/09/2024 10:02:50

brainstorm-cell-q4-eps-011-beats-015-estimate
Brainstorm Cell Q4 EPS $(0.11) Beats $(0.1...
04/01/2024 19:47:53

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.1...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/01/2024 16:31:03

brainstorm-cell-q4-earnings-insights
Brainstorm Cell: Q4 Earnings Insights
04/01/2024 14:35:08

brainstorm-cell-therapeutics-reported-fy23-eps-loss-of-040-cash-balance-of-145m
BrainStorm Cell Therapeutics Reported FY23...
04/01/2024 12:08:10

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/25/2024 21:32:19

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/20/2024 17:31:24

brainstorm-cell-therapeutics-has-been-granted-israeli-patent-number-277447-titled-cell-type-specific-exosomes-and-use-thereof-for-the-treatment-of-neurodegenerative-diseases
Brainstorm Cell Therapeutics Has Been Gran...
03/05/2024 17:17:51

https://israelpatents.justice.gov.il/search/en/patent-extract/277447

brainstorm-cell-therapeutics-will-present-a-poster-outlining-the-proposed-design-for-a-phase-3b-trial-of-nurown-in-amyotrophic-lateral-sclerosis-at-the-mda-clinical-and-scientific-conference-on-monday
Brainstorm Cell Therapeutics Will Present ...
02/27/2024 11:39:56

 The design is for a two-part, multicenter, Phase 3b study to assess the efficacy and safety of NurOwn in participants with ALS...

brainstorm-cell-therapeutics-submits-special-protocol-assessment-spa-request-to-fda-for-phase-3b-trial-of-nurown-in-amyotrophic-lateral-sclerosis
Brainstorm Cell Therapeutics Submits Speci...
02/23/2024 11:06:39

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
02/21/2024 21:31:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION